Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Brugia malayi | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Echinococcus granulosus | survival motor neuron protein 1 | Get druggable targets OG5_132873 | All targets in OG5_132873 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | fatty acid desaturase | 0.0092 | 0.0128 | 1 |
Trypanosoma brucei | cytochrome b5-dependent oleate desaturase | 0.0092 | 0.0128 | 0.0128 |
Mycobacterium ulcerans | linoleoyl-CoA desaturase, DesA3_2 | 0.0092 | 0.0128 | 0.5 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.2493 | 1 |
Trypanosoma brucei | delta-6 fatty acid desaturase, putative | 0.0092 | 0.0128 | 0.0128 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0809 | 0.8881 | 0.8867 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.2493 | 0.2702 |
Brugia malayi | acyl-CoA desaturase | 0.0809 | 0.8881 | 1 |
Toxoplasma gondii | sphingolipid delta 4 desaturase/c-4 hydroxylase protein des2 family protein | 0.0092 | 0.0128 | 0.5 |
Leishmania major | fatty-acid desaturase, putative | 0.0901 | 1 | 1 |
Loa Loa (eye worm) | acyl-CoA desaturase | 0.0809 | 0.8881 | 1 |
Plasmodium vivax | stearoyl-CoA desaturase (acyl-CoA desaturase, faty acid desaturase), putative | 0.0809 | 0.8881 | 0.5 |
Onchocerca volvulus | 0.0901 | 1 | 1 | |
Mycobacterium tuberculosis | Probable conserved membrane protein | 0.0092 | 0.0128 | 0.5 |
Mycobacterium tuberculosis | Probable transmembrane alkane 1-monooxygenase AlkB (alkane 1-hydroxylase) (lauric acid omega-hydroxylase) (omega-hydroxylase) (f | 0.0092 | 0.0128 | 0.5 |
Trypanosoma brucei | sphingolipid delta 4 desaturase, putative | 0.0092 | 0.0128 | 0.0128 |
Mycobacterium ulcerans | hypothetical protein | 0.0092 | 0.0128 | 0.5 |
Trypanosoma brucei | fatty acid desaturase, putative | 0.0901 | 1 | 1 |
Mycobacterium ulcerans | electron transfer protein FdxB | 0.0092 | 0.0128 | 0.5 |
Trypanosoma brucei | delta-4 fatty acid desaturase | 0.0092 | 0.0128 | 0.0128 |
Onchocerca volvulus | 0.0901 | 1 | 1 | |
Brugia malayi | hypothetical protein | 0.0286 | 0.2493 | 0.2702 |
Mycobacterium tuberculosis | Possible electron transfer protein FdxB | 0.0092 | 0.0128 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0092 | 0.0128 | 0.5 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0809 | 0.8881 | 0.8867 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.2493 | 1 |
Mycobacterium ulcerans | linoleoyl-CoA desaturase, DesA3 | 0.0092 | 0.0128 | 0.5 |
Mycobacterium ulcerans | transmembrane alkane 1-monooxygenase AlkB | 0.0092 | 0.0128 | 0.5 |
Plasmodium falciparum | stearoyl-CoA desaturase | 0.0809 | 0.8881 | 0.5 |
Mycobacterium ulcerans | linoleoyl-CoA desaturase, DesA3 | 0.0092 | 0.0128 | 0.5 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0901 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.0891 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.